-Cassyni was successfully acquired by Antharis Therapeutics Inc, in July 2022.
We developed monoclonal antibodies to fight human infectious and inflammatory diseases, and now continue these efforts under Antharis Therapeutics Inc.
Company Details
- Founded
- -
- Address
- San Diego, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- San Diego, CA
Cassyni Biopharma Questions
Cassyni Biopharma's LinkedIn profile is https://www.linkedin.com/company/cassynibiopharma
Cassyni Biopharma's industry is
Biotechnology Research
Cassyni Biopharma's top competitors are
Vitrolife & Igenomix Brasil, Part Of Vitrolife Group,
Episkin Sa,
Galileo Biotech,
Apc Biotecnologia,
Antharis Therapeutics, Inc.,
Aeterna Therapeutics,
Tillat Pharmaceuticals,
Receptabio,
Eitr Biologics, Inc.,
Bio Bureau Biotechnology.
Cassyni Biopharma's categories are Biotechnology Research
Cassyni Biopharma's founding year is 2020
